Trimazosin

	WikiDoc Resources for Trimazosin
Articles
Most recent articles on Trimazosin Most cited articles on Trimazosin Review articles on Trimazosin Articles on Trimazosin in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Trimazosin Images of Trimazosin Photos of Trimazosin Podcasts & MP3s on Trimazosin Videos on Trimazosin
Evidence Based Medicine
Cochrane Collaboration on Trimazosin Bandolier on Trimazosin TRIP on Trimazosin
Clinical Trials
Ongoing Trials on Trimazosin at Clinical Trials.gov Trial results on Trimazosin Clinical Trials on Trimazosin at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Trimazosin NICE Guidance on Trimazosin NHS PRODIGY Guidance FDA on Trimazosin CDC on Trimazosin
Books
Books on Trimazosin
News
Trimazosin in the news Be alerted to news on Trimazosin News trends on Trimazosin
Commentary
Blogs on Trimazosin
Definitions
Definitions of Trimazosin
Patient Resources / Community
Patient resources on Trimazosin Discussion groups on Trimazosin Patient Handouts on Trimazosin Directions to Hospitals Treating Trimazosin Risk calculators and risk factors for Trimazosin
Healthcare Provider Resources
Symptoms of Trimazosin Causes & Risk Factors for Trimazosin Diagnostic studies for Trimazosin Treatment of Trimazosin
Continuing Medical Education (CME)
CME Programs on Trimazosin
International
Trimazosin en Espanol Trimazosin en Francais
Business
Trimazosin in the Marketplace Patents on Trimazosin
Experimental / Informatics
List of terms related to Trimazosin

Trimazosin
Gene therapy
Clinical data
ATC code	C02CA03 (WHO) ;
Physiological data
Legal status
Pharmacokinetic data
Identifiers
	IUPAC name (2-hydroxy-2-methylpropyl) 4-(4-amino-6,7,8-trimethoxyquinazolin-2-yl)piperazine-1-carboxylate;
CAS Number	53746-46-6 ;
PubChem Template:Abbreviation	37264;
ChemSpider	34203 ;
UNII	31L760807H;
ChEMBL	ChEMBL513301 ;
Chemical and physical data
Formula	C20H29N5O6
Molar mass	435.47 g/mol
3D model (JSmol)	Interactive image;
	SMILES O=C(OCC(O)(C)C)N3CCN(c1nc(N)c2c(n1)c(OC)c(OC)c(OC)c2)CC3;
	InChI InChI=1S/C20H29N5O6/c1-20(2,27)11-31-19(26)25-8-6-24(7-9-25)18-22-14-12(17(21)23-18)10-13(28-3)15(29-4)16(14)30-5/h10,27H,6-9,11H2,1-5H3,(H2,21,22,23) ; Key:YNZXWQJZEDLQEG-UHFFFAOYSA-N ;
	Template:Xmark (what is this?) (verify)

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];

Overview

Trimazosin is a sympatholytic drug.

Hess, H. J.; 1972.

↑ van Kalken CK, van der Meulen J, Oe PL, Vriesendorp R, Donker AJ (1986). "Pharmacokinetics of trimazosin and its effects on blood pressure, renal function and proteinuria during short-term therapy of patients with impaired renal function and hypertension". Eur. J. Clin. Pharmacol. 31 (1): 63–8. doi:10.1007/BF00870988. PMID 3780829.

v t e Antihypertensives (C02) and diuretics (C03)
Sympatholytic agents	Template:Navbox subgroup
Vasodilators	Diazoxide • hydrazinophthalazine (Hydralazine, Dihydralazine, Endralazine, Cadralazine) • Minoxidil • Nitroprusside • Phentolamine
Other antihypertensives	serotonin antagonist (Ketanserin) • endothelin receptor antagonist (Bosentan, Ambrisentan, Sitaxsentan) • MAOI (Pargyline) • THI (Metirosine)
Diuretics	Template:Navbox subgroup

Gene therapy

Clinical data
ATC code	C02CA03 (WHO)
Physiological data
Legal status
Pharmacokinetic data
Identifiers
IUPAC name (2-hydroxy-2-methylpropyl) 4-(4-amino-6,7,8-trimethoxyquinazolin-2-yl)piperazine-1-carboxylate
CAS Number	53746-46-6^Y
PubChem Template:Abbreviation	37264
ChemSpider	34203^N
UNII	31L760807H
ChEMBL	ChEMBL513301^N
Chemical and physical data
Formula	C₂₀H₂₉N₅O₆
Molar mass	435.47 g/mol
3D model (JSmol)	Interactive image
SMILES O=C(OCC(O)(C)C)N3CCN(c1nc(N)c2c(n1)c(OC)c(OC)c(OC)c2)CC3
InChI InChI=1S/C20H29N5O6/c1-20(2,27)11-31-19(26)25-8-6-24(7-9-25)18-22-14-12(17(21)23-18)10-13(28-3)15(29-4)16(14)30-5/h10,27H,6-9,11H2,1-5H3,(H2,21,22,23)^N Key:YNZXWQJZEDLQEG-UHFFFAOYSA-N^N
^{Template:XmarkY} (what is this?) (verify)